Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
BEAM
BEAM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BEAM News
Gene Drive Technology as a Solution to Invasive Species
Apr 12 2026
Yahoo Finance
Beam Therapeutics CEO John Evans Sells Shares Amid Positive Clinical Data
Apr 11 2026
NASDAQ.COM
Beam Therapeutics CEO Sells Shares Amid Positive Clinical Data
Apr 11 2026
Fool
Beam's Therapy Shows Promising Efficacy for Sickle Cell Disease
Apr 02 2026
stocktwits
Risto-cel Clinical Data Significantly Improves Sickle Cell Disease Outcomes
Apr 01 2026
Newsfilter
Beam Therapeutics Advances Gene Therapy Development for AAT Deficiency
Mar 25 2026
seekingalpha
Beam Therapeutics Shares Surge on Promising Gene Therapy Data
Mar 25 2026
stocktwits
What Caused BEAM Stock to Rise 10% in Pre-Market Trading Today?
Mar 25 2026
stocktwits
BEAM-302 Clinical Trial Data Update
Mar 25 2026
Newsfilter
Beam Therapeutics Stock Soars to New Heights
Feb 24 2026
Benzinga
Beam Therapeutics Reports Q4 Earnings Exceeding Expectations
Feb 24 2026
seekingalpha
Beam Therapeutics Executive Sells Shares
Feb 01 2026
Fool
Wall Street Focuses on Earnings and Commodity Prices
Jan 29 2026
stocktwits
ARK Invest Deepens AI Chip and Gene Editing Investments, Sells 86K Tesla Shares
Jan 19 2026
seekingalpha
BEAM Options Analysis: Put Contract Offers 11.29% YieldBoost
Jan 13 2026
NASDAQ.COM
Beam Therapeutics (BEAM) to Submit Biologics License Application for Risto-cel by End of 2026
Jan 12 2026
stocktwits
Show More News
